The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
PreviousPrevious
Volume 349:1016-1018 September 11, 2003 Number 11
NextNext

Assessing Risk in Hypertrophic Cardiomyopathy
Richard O. Cannon, III, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Cecchi, F.
-PubMed Citation
Hypertrophic cardiomyopathy has fascinated clinicians and clinical investigators since its initial description almost 50 years ago because of the unique physical findings, often bizarre electrocardiographic aspects, unusual shape of the left ventricle on contrast ventriculography, typically asymmetric distribution of hypertrophy on echocardiography, and abnormal filling of the left ventricle in diastole. Some aspects of the disease have generated considerable controversy, such as the mechanism (and even the existence) of dynamic intraventricular pressure gradients in some patients.

No less contentious is the debate about how clinicians might predict the most feared complication of this disease: sudden death. Although clinical predictors of . . . [Full Text of this Article]


Source Information

From the National Heart, Lung, and Blood Institute, Bethesda, Md.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.